BioLean® System

Fish Oil Prevents Drop in Heart Rate Variability Due to Indoor Air Pollution

News Author: Megan Rauscher
CME Author: Hien T. Nghiem, MD

Dec. 22, 2005 (Reuters) — Daily omega-3 fatty acid supplementation prevents a decline in heart rate variability (HRV) associated with indoorexposure to fine particulate matter, a common air pollutant, researchers from the US and Canada report.

"A lower HRV may increase the risk of a susceptible person to have a serious cardiac arrhythmia," study investigator Dr. Fernando Holguin from the Centers for Disease Control and Prevention in Atlanta told Reuters Health. "In the future, when we identify who is most susceptible to the effects of particulate matter, we could recommend supplementation with omega-3 fatty acids to reduce their cardiovascular risk," he added.

Environmental exposure to airborne particulate matter of 2.5 microns in diameter or less (PM-2.5) has been associated with reductions in HRV, a measure of cardiac autonomic regulation, and increased cardiovascular mortality in the elderly, Dr. Holguin and colleagues explain in the second issue of the December American Journal of Respiratory and Critical Care Medicine.

"We and others theorize that PM-2.5 - associated reductions in HRV are a potential mechanism by which PM-2.5 leads to increased cardiovascular morbidity and mortality," Dr. Holguin said.

To investigate, 50 relatively healthy elderly nursing home residents who were free of cardiovascular disease other than hypertension were randomly allocated to 2 grams of fish oil or 2 grams of soy (control) oil daily for 5 months. The researchers say that the fish oil comprised 83.2% omega-3 polyunsaturated fatty acids (n-3 PUFA), and the soy oil 6.7%.

All of the participants had a low intake of n-3 PUFA at baseline and spent 92% of their time indoors. Their average age was 82 years.

All subjects underwent six-minute supine HRV measurement every other day. In the fish oil arm, during the 30-day presupplementation phase, there was a significant 54% reduction in HRV per standard deviation of PM-2.5 (8.0 micrograms/m³); that compared with a reduction of only 7% in HRV per SD PM-2.5 during the fish oil supplementation phase.

Supplementation with soy oil, on the other hand, was associated with "a marginal, nonsignificant protection from the effects of PM-2.5 on HRV," the investigators write.

"Our study shows for the first time that the (effect) of PM-2.5 on HRV was substantially reduced in an elderly group of participants randomized to two grams per day of fish oil," Dr. Holguin said.

Fish oil, as a source of n-3 PUFA, "could be considered a potential form of preventive measure to reduce the risk of arrhythmia and sudden death in elderly subjects exposed to ambient air pollution," he and his colleagues conclude.

"However, larger intervention studies are needed to confirm the modulating effect of n-3 PUFA on the adverse cardiovascular outcomes related to air pollution exposure in susceptible populations and to clarify the dose-response relationship," they add.

Am J Respir Crit Care Med. 2005;172:1534-1540

back to top


  • Omega-3 fatty acids for the prevention and treatment of atherosclerotic diseases
    -- read

  • Fish Oil Added to Statin Therapy Reduces Risk For Major Coronary Events
    -- read

  • Fish oil supplements plus statins protect against heart disease
    -- read

  • Omega-3 fatty acids in the prevention and treatment of cardiovascular disease
    -- read

  • Fish Oil Prevents Drop in Heart Rate Variability Due to Indoor Air Pollution
    -- read


  • Women catching up on cardiovascular heart disease. Omega-3 important for prevention and treatment.
    -- read

  • Cardiovascular Research
    -- read





WINOmeg3complexTM | Understanding Omega-3 | Are you getting enough? | FAQ
Heart | Brain | Joints | Vision | Children & Pregnancy | Other Health Issues

© 2005-2008 by Wellness International Network, Ltd. All rights reserved.

The information contained herein has not, to WIN’s knowledge, been evaluated by the Food and Drug Administration. WIN does not sell or market its products with intent to diagnose, treat, cure, mitigate or prevent any specific disease or class of diseases.